On July 30, China's Price, Cost and Certification Center convened selected
domestic innovative biopharma firms to gather information on recent industry
developments, emerging issues and outlook, and to solicit input for planned
follow-up research.
2026-08-12
On July 30, China's Price, Cost and Certification Center convened selected
domestic innovative biopharma firms to gather information on recent industry
developments, emerging issues and outlook, and to solicit input for planned
follow-up research.